These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 23596299)

  • 1. Inhibition of hepatitis C virus (HCV) replication by specific RNA aptamers against HCV NS5B RNA replicase.
    Lee CH; Lee YJ; Kim JH; Lim JH; Kim JH; Han W; Lee SH; Noh GJ; Lee SW
    J Virol; 2013 Jun; 87(12):7064-74. PubMed ID: 23596299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interference of HCV replication by cell penetrable human monoclonal scFv specific to NS5B polymerase.
    Thueng-in K; Thanongsaksrikul J; Jittavisutthikul S; Seesuay W; Chulanetra M; Sakolvaree Y; Srimanote P; Chaicumpa W
    MAbs; 2014; 6(5):1327-39. PubMed ID: 25517317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis C virus (HCV) RNA polymerase by DNA aptamers: mechanism of inhibition of in vitro RNA synthesis and effect on HCV-infected cells.
    Bellecave P; Cazenave C; Rumi J; Staedel C; Cosnefroy O; Andreola ML; Ventura M; Tarrago-Litvak L; Astier-Gin T
    Antimicrob Agents Chemother; 2008 Jun; 52(6):2097-110. PubMed ID: 18347106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of hepatitis C virus infection by DNA aptamer against NS2 protein.
    Gao Y; Yu X; Xue B; Zhou F; Wang X; Yang D; Liu N; Xu L; Fang X; Zhu H
    PLoS One; 2014; 9(2):e90333. PubMed ID: 24587329
    [TBL] [Abstract][Full Text] [Related]  

  • 5. RNA aptamer-mediated interference of HCV replication by targeting the CRE-5BSL3.2 domain.
    Marton S; Romero-López C; Berzal-Herranz A
    J Viral Hepat; 2013 Feb; 20(2):103-12. PubMed ID: 23301545
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specific inhibitors of HCV polymerase identified using an NS5B with lower affinity for template/primer substrate.
    McKercher G; Beaulieu PL; Lamarre D; LaPlante S; Lefebvre S; Pellerin C; Thauvette L; Kukolj G
    Nucleic Acids Res; 2004; 32(2):422-31. PubMed ID: 14739234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of hepatitis C virus infection by NS5A-specific aptamer.
    Yu X; Gao Y; Xue B; Wang X; Yang D; Qin Y; Yu R; Liu N; Xu L; Fang X; Zhu H
    Antiviral Res; 2014 Jun; 106():116-24. PubMed ID: 24713119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Selection of DNA aptamers that bind the RNA-dependent RNA polymerase of hepatitis C virus and inhibit viral RNA synthesis in vitro.
    Bellecave P; Andreola ML; Ventura M; Tarrago-Litvak L; Litvak S; Astier-Gin T
    Oligonucleotides; 2003; 13(6):455-63. PubMed ID: 15025912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The C-terminal transmembrane domain of hepatitis C virus (HCV) RNA polymerase is essential for HCV replication in vivo.
    Lee KJ; Choi J; Ou JH; Lai MM
    J Virol; 2004 Apr; 78(7):3797-802. PubMed ID: 15016899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phosphorylation of hepatitis C virus RNA polymerases ser29 and ser42 by protein kinase C-related kinase 2 regulates viral RNA replication.
    Han SH; Kim SJ; Kim EJ; Kim TE; Moon JS; Kim GW; Lee SH; Cho K; Yoo JS; Son WS; Rhee JK; Han SH; Oh JW
    J Virol; 2014 Oct; 88(19):11240-52. PubMed ID: 25031343
    [TBL] [Abstract][Full Text] [Related]  

  • 11. PSI-7851, a pronucleotide of beta-D-2'-deoxy-2'-fluoro-2'-C-methyluridine monophosphate, is a potent and pan-genotype inhibitor of hepatitis C virus replication.
    Lam AM; Murakami E; Espiritu C; Steuer HM; Niu C; Keilman M; Bao H; Zennou V; Bourne N; Julander JG; Morrey JD; Smee DF; Frick DN; Heck JA; Wang P; Nagarathnam D; Ross BS; Sofia MJ; Otto MJ; Furman PA
    Antimicrob Agents Chemother; 2010 Aug; 54(8):3187-96. PubMed ID: 20516278
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The novel nucleoside analog R1479 (4'-azidocytidine) is a potent inhibitor of NS5B-dependent RNA synthesis and hepatitis C virus replication in cell culture.
    Klumpp K; Lévêque V; Le Pogam S; Ma H; Jiang WR; Kang H; Granycome C; Singer M; Laxton C; Hang JQ; Sarma K; Smith DB; Heindl D; Hobbs CJ; Merrett JH; Symons J; Cammack N; Martin JA; Devos R; Nájera I
    J Biol Chem; 2006 Feb; 281(7):3793-9. PubMed ID: 16316989
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silibinin and related compounds are direct inhibitors of hepatitis C virus RNA-dependent RNA polymerase.
    Ahmed-Belkacem A; Ahnou N; Barbotte L; Wychowski C; Pallier C; Brillet R; Pohl RT; Pawlotsky JM
    Gastroenterology; 2010 Mar; 138(3):1112-22. PubMed ID: 19962982
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cell-based assay for RNA synthesis by the HCV polymerase reveals new insights on mechanism of polymerase inhibitors and modulation by NS5A.
    Ranjith-Kumar CT; Wen Y; Baxter N; Bhardwaj K; Cheng Kao C
    PLoS One; 2011; 6(7):e22575. PubMed ID: 21799903
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B
    Schult P; Nattermann M; Lauber C; Seitz S; Lohmann V
    J Virol; 2019 Oct; 93(19):. PubMed ID: 31315989
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron inactivates the RNA polymerase NS5B and suppresses subgenomic replication of hepatitis C Virus.
    Fillebeen C; Rivas-Estilla AM; Bisaillon M; Ponka P; Muckenthaler M; Hentze MW; Koromilas AE; Pantopoulos K
    J Biol Chem; 2005 Mar; 280(10):9049-57. PubMed ID: 15637067
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cooperation between the Hepatitis C Virus p7 and NS5B Proteins Enhances Virion Infectivity.
    Aligeti M; Roder A; Horner SM
    J Virol; 2015 Nov; 89(22):11523-33. PubMed ID: 26355084
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A genotype 2b NS5B polymerase with novel substitutions supports replication of a chimeric HCV 1b:2b replicon containing a genotype 1b NS3-5A background.
    Graham DJ; Stahlhut M; Flores O; Olsen DB; Hazuda DJ; Lafemina RL; Ludmerer SW
    Antiviral Res; 2006 Jan; 69(1):24-30. PubMed ID: 16297457
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of aurintricarboxylic acid as a potent hepatitis C virus replicase inhibitor.
    Chen Y; Bopda-Waffo A; Basu A; Krishnan R; Silberstein E; Taylor DR; Talele TT; Arora P; Kaushik-Basu N
    Antivir Chem Chemother; 2009 Sep; 20(1):19-36. PubMed ID: 19794229
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemical genetics-based discovery of indole derivatives as HCV NS5B polymerase inhibitors.
    Jin G; Lee S; Choi M; Son S; Kim GW; Oh JW; Lee C; Lee K
    Eur J Med Chem; 2014 Mar; 75():413-25. PubMed ID: 24561671
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.